Edelfosine: an antitumor drug prototype (2018)
Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, IMUNOLOGIA, QUIMIOTERÁPICOS, NEOPLASIAS PULMONARES, SISTEMA IMUNE, FOSFOLIPÍDEOS, PACIENTES, CITOMETRIA DE FLUXO, CITOTOXICIDADE IMUNOLÓGICA
ABNT
TEIXEIRA, Sarah Fernandes et al. Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, v. 18, n. 6, p. 865-874, 2018Tradução . . Disponível em: https://doi.org/10.2174/1871520618666180105165431. Acesso em: 05 nov. 2024.APA
Teixeira, S. F., Rodrigues, C. P., Costa, C. J. S., Pettinati, T. N., Azevedo, R. A. de, Mambelli, L. I., et al. (2018). Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, 18( 6), 865-874. doi:10.2174/1871520618666180105165431NLM
Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/1871520618666180105165431Vancouver
Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/1871520618666180105165431